by synergycap1 | Jun 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
China has called off plans for top-level talks with South Korea and Japan, according to reports. The trilateral summit was expected to take place in late July. Beijing notified Tokyo that that time won’t work, although the controversy over the U.S.-supplied...
by synergycap1 | Jun 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Some hospital executives in states with senators critical to passing a healthcare reform bill have made their opposition to the legislation known and they’re keeping a laser focus on Medicaid expansion.Doug Bentz, CEO of Roane General Hospital in Spencer, W.Va.,...
by synergycap1 | Jun 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Non-Bank Loans, Working Capital
Click to learn more about Kelsey Trail Trucking.
by synergycap1 | Jun 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Working Capital
The Regional Transportation District says it’s encouraged by ongoing tests of the commuter train through Arvada and Wheatridge, but the transit agency still doesn’t yet know whether it will be able to open the G Line this year. “The testing is going...
by synergycap1 | Jun 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Immigration and Emigration, Muslims and Islam, Non-Bank Loans, Refugees and Displaced Persons, Trump, Donald J, United States International Relations, United States Politics and Government, Working Capital
By GARDINER HARRIS and MICHAEL D. SHEAR June 29, 2017 WASHINGTON — The Trump administration on Thursday moved aggressively to fulfill one of the president’s most contentious campaign promises, banning entry into the United States...
by synergycap1 | Jun 29, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Startup, Working Capital
We hear the term “BioTech” thrown around all the time. Personally, I have more of a pulse on what’s happening with pharma bro Martin Shkreli–that guy infamous for unapologetically raising an AIDS drug from $13.50 to $750 per tablet who starts...
